Collegium Pharmaceutical issues 2026 financial guidance
Go back to Collegium Pharmaceutical issues 2026 financial guidance| (NASDAQ: COLL) | Delayed: 36.59 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.59 | 52 Week High | $30.58 | |||
| Open | $0.00 | 52 Week Low | $8.24 | |||
| Day High | $36.59 | P/E | N/A | |||
| Day Low | $36.59 | EPS | $0.00 | |||
| Volume | 0 | |||||

